Immunogenicity of a third dose of inactivated COVID-19 vaccine in people living with HIV-1, HBV, and tuberculosis during the Omicron variant epidemic: A cross-sectional study.

Yan Yan Chantsalmaa Davgadorj Chunyan Lyu Shiliang Zhang Yuanwang Qiu

J Infect

The International Joint Research Laboratory for Infection and Immunity (China-Germany), Jiangnan University, Wuxi, China; Hepatology Institute of Wuxi, The Fifth People's Hospital of Wuxi (Wuxi Infectious Disease Hospital), Affiliated Hospital of Jiangnan University, Wuxi, China. Electronic address:

Published: October 2022

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254457	PMC
http://dx.doi.org/10.1016/j.jinf.2022.06.032	DOI Listing

Publication Analysis

Top Keywords

immunogenicity third

third dose

dose inactivated

inactivated covid-19

covid-19 vaccine

vaccine people

people living

living hiv-1

hiv-1 hbv

hbv tuberculosis

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!